New technology allows testing after biopsies using only tumor cells normally discarded as medical waste –- concept could spare some patients from chemotherapy 

User interface designed for clinical oncologists as well as the targeted therapy research community

LA JOLLA, CA–November 17, 2025 – Corramedical, Inc. announced today that its name has changed to Virchow Medical, signaling a transformative new chapter for the industry leader in biological specimen stewardship.

LA JOLLA, CA, UNITED STATES, June 23, 2025 /EINPresswire.com/ — Corramedical, Inc., a leader in innovative biopsy specimen technologies, is now accepting applications for the 2025 Biopsy Catchment Biobank Investigators Award.

A new publication in the Journal of Clinical Oncology (J Clin Oncol. 2025;43(16):e13898) by Drs. Saloni Walia and Pamela Ward at USC Medical Center describes a novel method to enhance tumor biopsy analysis.

Board Will Accelerate Company’s Mission to Make Precision Medicine Available to More Patients; Thought Leaders in Pathology, Oncology, Radiology, and Genomic Sequencing